Oscar Health Forecasts $18.85B 2026 Revenue, Shares Jump Over 4%
Oscar Health reported a fourth-quarter 2025 loss of $1.24 per share and revenue of $2.81 billion, both missing analyst estimates. The company forecast 2026 revenue of $18.85 billion at the midpoint, far above the $12.76 billion consensus, sending shares up over 4%.
1. Fourth-Quarter Performance
Oscar Health reported a Q4 2025 loss of $1.24 per share, wider than estimates, with revenue of $2.81 billion, undershooting consensus and reflecting ongoing cost pressures in its insurance operations.
2. 2026 Revenue Guidance
Management projected full-year 2026 revenue of $18.85 billion at the midpoint, significantly surpassing the $12.76 billion analyst consensus, signaling confidence in member growth and service demand.
3. Market Reaction and Volatility
Shares rallied as much as 4.8% on the outlook before settling up 4.1% at $13.18; the stock has experienced 55 moves exceeding 5% over the past year, highlighting high trading volatility.
4. Investor Sentiment and Historical Returns
Oscar Health is down 12% year-to-date and trading 41.3% below its 52-week high of $22.47, while institutional shifts—such as Blue Square Asset Management’s sale of 17,462 shares—underscore mixed confidence among major investors.